Dr Shanise Fleming, DC | |
599 Silver St, Coventry, CT 06238-1516 | |
(860) 989-7608 | |
Not Available |
Full Name | Dr Shanise Fleming |
---|---|
Gender | Female |
Speciality | Chiropractor - Independent Medical Examiner |
Location | 599 Silver St, Coventry, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538765755 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111NI0013X | Chiropractor - Independent Medical Examiner | 2206 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Shanise Fleming, DC 599 Silver St, Coventry, CT 06238-1516 Ph: (860) 989-7608 | Dr Shanise Fleming, DC 599 Silver St, Coventry, CT 06238-1516 Ph: (860) 989-7608 |
News Archive
For decades, medical wisdom about shingles has been that it's a once-in-a-lifetime experience. The commonly-held belief is that patients are protected from a recurrence of the herpes zoster virus, which causes shingles, after one episode. But according to a study published in the February issue of Mayo Clinic Proceedings, recurrences of shingles may be significantly more common than doctors have suspected.
Recognizing that both women and their doctors are often confused after a mammogram reveals the woman has dense breasts, a nonprofit organization has launched a major new educational website. The site, www.DenseBreast-info.org, addresses questions women and their healthcare providers often have about breast density - helping them to "Get Smart about Being Dense."
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced completion of patient enrollment in its pivotal clinical study of the APPY1 Test in the United States.
Medical News Today recently reported that America's pharmaceutical research and biotechnology companies are working on nearly 100 life-changing medicines for diseases affecting people with HIV/AIDS, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA).
› Verified 8 days ago